CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.
Manufactured by
Shenzhen Microprofit Biotech Co., Ltd
Shenzhen, China
Headquartered in Microprofit Building, Shenzhen, Microprofit Biotech was established in 2009. As a national-level high-tech enterprise, we specialize in the integrated production, research, and sales of cutting-edge IVD products with our own GMP Workshop. With our independent brand, fluorecare®, our products have gained popularity in 100+ countries and regions. We prioritize quality and focus on the field of in-vitro diagnostics, striving to create a new impact on point-of-care testing (POCT) and benefit healthcare professionals and patients worldwide. Embracing technological innovation, we aim to make a difference in people's lives.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Beijing Zhongjian Antai Diagnostic Co., Ltd.
China · 1 relevant product
B&C Biological
China · 2 relevant products
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 32 closest product alternatives
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.
B&C Biological · China
A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
29 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products